Goldman Sachs
ANIP icon

Goldman Sachs’s ANI Pharmaceuticals ANIP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$13.4M Sell
205,620
-426,166
-67% -$27.8M ﹤0.01% 2047
2025
Q1
$42.3M Sell
631,786
-67,832
-10% -$4.54M 0.01% 1155
2024
Q4
$38.7M Sell
699,618
-16,451
-2% -$909K 0.01% 1271
2024
Q3
$42.7M Buy
716,069
+626,110
+696% +$37.4M 0.01% 1172
2024
Q2
$5.73M Buy
89,959
+24,169
+37% +$1.54M ﹤0.01% 2513
2024
Q1
$4.55M Buy
65,790
+24,589
+60% +$1.7M ﹤0.01% 2644
2023
Q4
$2.27M Buy
41,201
+2,007
+5% +$111K ﹤0.01% 3118
2023
Q3
$2.28M Sell
39,194
-34,021
-46% -$1.98M ﹤0.01% 3012
2023
Q2
$3.94M Buy
73,215
+6,066
+9% +$327K ﹤0.01% 2735
2023
Q1
$2.67M Sell
67,149
-5,237
-7% -$208K ﹤0.01% 3008
2022
Q4
$2.91M Sell
72,386
-20,240
-22% -$814K ﹤0.01% 3017
2022
Q3
$2.98M Sell
92,626
-43,183
-32% -$1.39M ﹤0.01% 3047
2022
Q2
$4.03M Buy
135,809
+120,178
+769% +$3.57M ﹤0.01% 2848
2022
Q1
$439K Sell
15,631
-22,564
-59% -$634K ﹤0.01% 4654
2021
Q4
$1.76M Sell
38,195
-273,067
-88% -$12.6M ﹤0.01% 3585
2021
Q3
$10.2M Sell
311,262
-50,482
-14% -$1.66M ﹤0.01% 2253
2021
Q2
$12.7M Buy
361,744
+23,376
+7% +$819K ﹤0.01% 2079
2021
Q1
$12.2M Sell
338,368
-4,160
-1% -$150K ﹤0.01% 2057
2020
Q4
$9.95M Buy
342,528
+30,269
+10% +$879K ﹤0.01% 2063
2020
Q3
$8.81M Buy
312,259
+38,400
+14% +$1.08M ﹤0.01% 2030
2020
Q2
$8.86M Sell
273,859
-7,562
-3% -$245K ﹤0.01% 2017
2020
Q1
$11.5M Buy
281,421
+2,691
+1% +$110K ﹤0.01% 1726
2019
Q4
$17.2M Buy
278,730
+53,577
+24% +$3.3M ﹤0.01% 1716
2019
Q3
$16.4M Buy
225,153
+178,875
+387% +$13M ﹤0.01% 1649
2019
Q2
$3.8M Sell
46,278
-8,935
-16% -$734K ﹤0.01% 2448
2019
Q1
$3.9M Buy
55,213
+3,375
+7% +$238K ﹤0.01% 2589
2018
Q4
$2.33M Sell
51,838
-53,066
-51% -$2.39M ﹤0.01% 2732
2018
Q3
$5.93M Buy
104,904
+10,750
+11% +$608K ﹤0.01% 2333
2018
Q2
$6.29M Buy
94,154
+11,856
+14% +$792K ﹤0.01% 2289
2018
Q1
$4.79M Buy
82,298
+47,018
+133% +$2.74M ﹤0.01% 2367
2017
Q4
$2.27M Sell
35,280
-8,186
-19% -$528K ﹤0.01% 2762
2017
Q3
$2.28M Buy
43,466
+27,223
+168% +$1.43M ﹤0.01% 2802
2017
Q2
$760K Sell
16,243
-4,336
-21% -$203K ﹤0.01% 3293
2017
Q1
$1.02M Sell
20,579
-3,014
-13% -$149K ﹤0.01% 3097
2016
Q4
$1.43M Buy
23,593
+10,987
+87% +$666K ﹤0.01% 2899
2016
Q3
$836K Buy
12,606
+3,018
+31% +$200K ﹤0.01% 3155
2016
Q2
$535K Sell
9,588
-6,301
-40% -$352K ﹤0.01% 3284
2016
Q1
$535K Buy
15,889
+3,432
+28% +$116K ﹤0.01% 3189
2015
Q4
$562K Buy
12,457
+2,848
+30% +$128K ﹤0.01% 3188
2015
Q3
$380K Sell
9,609
-19,452
-67% -$769K ﹤0.01% 3469
2015
Q2
$1.8M Buy
29,061
+10,972
+61% +$681K ﹤0.01% 2617
2015
Q1
$1.13M Buy
+18,089
New +$1.13M ﹤0.01% 2827
2014
Q3
Sell
-30,201
Closed -$1.04M 4500
2014
Q2
$1.04M Buy
30,201
+21,952
+266% +$756K ﹤0.01% 2940
2014
Q1
$259K Buy
+8,249
New +$259K ﹤0.01% 3761
2013
Q3
Sell
-32,908
Closed -$33K 4184
2013
Q2
$33K Buy
+32,908
New +$33K ﹤0.01% 3927